|
Volumn 40, Issue 3, 2001, Pages 448-456
|
Effect of reboxetine treatment on brain cAMP- and calcium/calmodulin-dependent protein kinases
|
Author keywords
Antidepressant; Calcium; Cyclic AMP; Protein kinase; Protein phosphorylation; Reboxetine
|
Indexed keywords
CYCLIC AMP BINDING PROTEIN;
CYCLIC AMP DEPENDENT PROTEIN KINASE;
MICROTUBULE ASSOCIATED PROTEIN 2;
PROTEIN KINASE (CALCIUM,CALMODULIN);
PROTEIN SUBUNIT;
REBOXETINE;
SYNAPSIN;
SYNAPTOTAGMIN;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DRUG EFFECT;
MICROTUBULE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN BINDING;
PROTEIN EXPRESSION;
PROTEIN PHOSPHORYLATION;
RAT;
SYNAPSE VESICLE;
SYNAPTIC MEMBRANE;
ADRENERGIC UPTAKE INHIBITORS;
ANIMALS;
ANTIDEPRESSIVE AGENTS;
BLOTTING, WESTERN;
BRAIN;
CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE;
CARRIER PROTEINS;
CEREBRAL CORTEX;
CYCLIC AMP RECEPTOR PROTEIN;
CYCLIC AMP-DEPENDENT PROTEIN KINASES;
DRUG ADMINISTRATION SCHEDULE;
HIPPOCAMPUS;
MALE;
MORPHOLINES;
PHOSPHORYLATION;
RATS;
RATS, SPRAGUE-DAWLEY;
SUBCELLULAR FRACTIONS;
SYNAPTIC VESICLES;
SYNAPTOSOMES;
|
EID: 0035130444
PISSN: 00283908
EISSN: None
Source Type: Journal
DOI: 10.1016/S0028-3908(00)00164-7 Document Type: Article |
Times cited : (14)
|
References (31)
|